Founded in March 2017 and based in Chengdu, Sichuan, Chengdu Daoerji Medical Technology Co., Ltd. focuses on the R&D, customization, and production of pharmaceutical intermediates, serving pharmaceutical companies around the world with professional expertise and high-quality solutions.

Our core strength lies in the development of heterocyclic compounds, covering categories such as pyridines, pyrans, pyrazines, pyrazoles, thiophenes, thiazoles, quinolines, piperidines, indoles, and quinones. In terms of process innovation, we have successfully developed synthesis technologies for anthraquinone derivatives like tetrahydrodiethylanthraquinone, as well as synthetic routes for diphenyl ether compounds such as morobenzen.

To date, we have been granted 20 patents, reflecting our ongoing commitment to innovation and technical advancement. Guided by the values of integrity, efficiency, and customer focus, we are dedicated to building long-term, mutually beneficial partnerships with our clients through reliable products and sincere service.